<DOC>
	<DOCNO>NCT03042429</DOCNO>
	<brief_summary>Improvement event free survival high-risk neuroblastoma patient introduction two additional topotecan contain chemotherapy cycle multimodal standard treatment ( induction chemotherapy , myeloablative therapy , radiation , surgery indicate , consolidation therapy ) .</brief_summary>
	<brief_title>Combination Chemotherapy Followed Stem Cell Transplant High-risk Neuroblastoma Patients</brief_title>
	<detailed_description>Experimental intervention ( 6 week + duration control intervention ) : 2 x N8 cycle ( topotecan , cyclophosphamide , etoposide ) follow standard arm treatment ( i.e. , control intervention ) Control intervention ( total duration 70-76 week ) : 3 x N5 cycle ( cisplatin , etoposide , vindesine ) 3 x N6 cycle ( vincristine , dacarbacine , ifosfamide , doxorubicine ) , myeloablative chemotherapy autologous stem cell transplantation ( melphalan , carboplatin , etoposide ) 9 x retinoic acid cycle ( 6 month , 3 month break , 3 month ) supportive care ( PCP/fungal prophylaxis , transfusion , antibiotic , G-CSF )</detailed_description>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<mesh_term>Vindesine</mesh_term>
	<mesh_term>Isotretinoin</mesh_term>
	<criteria>neuroblastoma stage 4 neuroblastoma age ≥1 21 year MYCN amplification age ≥6 month 21 year informed consent obtain Participation trial Pregnancy , lactation , insufficient contraception girl childbearing age , Any concomitant nonprotocol anticancer therapy , Incomplete initial staging .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>neuroblastoma</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>autologous stem cell transplantation</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>mIBG</keyword>
	<keyword>tumor resection</keyword>
</DOC>